nad has been researched along with Cervical Tuberculous Lymphadenitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, P; Dong, WZ; Liu, RM; Lu, J; Pang, Y; Shi, J; Wen, SA; Zhang, TT | 1 |
1 other study(ies) available for nad and Cervical Tuberculous Lymphadenitis
| Article | Year |
|---|---|
The putative NAD(P)H Nitroreductase, Rv3131, is the Probable Activating Enzyme for Metronidazole in
Topics: Bacterial Proteins; Humans; Metronidazole; Mycobacterium tuberculosis; NAD; Nitroreductases; Tuberculosis, Lymph Node | 2022 |